Becton, Dickinson and Company

NYSE:BDX Lagerbericht

Marktkapitalisierung: US$66.6b

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Becton Dickinson Management

Management Kriterienprüfungen 4/4

Becton Dickinson's CEO ist Tom Polen , ernannt in Apr 2017, hat eine Amtszeit von 4.25 Jahren. Die jährliche Gesamtvergütung beträgt $17.31M , bestehend aus 7.6% Gehalt und 92.4% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.02% der Aktien des Unternehmens, im Wert von $13.77M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.4 Jahre bzw. 6.5 Jahre.

Wichtige Informationen

Tom Polen

Geschäftsführender

US$17.3m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts7.6%
Amtszeit als Geschäftsführer7.1yrs
Eigentum des Geschäftsführers0.02%
Durchschnittliche Amtszeit des Managements2.5yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder6.5yrs

Jüngste Management Updates

Recent updates

Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?

May 24
Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?

Becton, Dickinson and Company: Stagnating All Along

May 16

Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)

Mar 23
Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)

Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)

Feb 29
Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)

Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings

Feb 08
Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings

Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 03
Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Feb 01
These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Becton, Dickinson: 4 Reasons To Buy This Growth At A Reasonable Price Play

Jan 22

Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 30
Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year

Becton, Dickinson And Company: Strong Q4 But Clouded By 75bps Growth Headwind From China In FY24

Nov 13

Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's

Nov 12
Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's

Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price

Nov 06
Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price

With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case

Oct 05
With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case

Becton, Dickinson Stock Is A Hold, Here's Why

Oct 04

Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers

Aug 30

We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Aug 13
We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Jul 28
Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching

Jun 22
Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching

Becton, Dickinson and Company: Still Not Very Healthy

Jun 20

Becton, Dickinson: Business Should Beat H2 2023 Expectations

Jun 08

These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Apr 22
These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Is Now The Time To Put Becton Dickinson (NYSE:BDX) On Your Watchlist?

Mar 20
Is Now The Time To Put Becton Dickinson (NYSE:BDX) On Your Watchlist?

Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Mar 05
Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Becton, Dickinson HPV test Onclarity gets FDA nod for expanded use

Feb 21

Becton, Dickinson wins FDA nod for flu, COVID, RSV combo test

Feb 08

Becton, Dickinson Q1 2023 Earnings Preview

Feb 01

Becton, Dickinson declares $0.91 dividend

Jan 24

We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Jan 09
We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

CerTest/Becton, Dickinson's test for monkeypox gets FDA emergency use nod

Jan 09

Becton, Dickinson: A Quality Defensive Pick For 2023

Dec 20

Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Dec 01
Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Becton Dickinson (NYSE:BDX) Is Increasing Its Dividend To $0.91

Nov 13
Becton Dickinson (NYSE:BDX) Is Increasing Its Dividend To $0.91

Becton, Dickinson Q4 2022 Earnings Preview

Nov 09

Becton, Dickinson, Biocorp team up for traceability of injectable drugs

Oct 18

Becton, Dickinson: Buy In Now While You Can

Oct 12

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Tom Polen im Vergleich zu den Einnahmen von Becton Dickinson verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Mar 31 2024n/an/a

US$1b

Dec 31 2023n/an/a

US$1b

Sep 30 2023US$17mUS$1m

US$1b

Jun 30 2023n/an/a

US$2b

Mar 31 2023n/an/a

US$2b

Dec 31 2022n/an/a

US$1b

Sep 30 2022US$17mUS$1m

US$2b

Jun 30 2022n/an/a

US$1b

Mar 31 2022n/an/a

US$1b

Dec 31 2021n/an/a

US$1b

Sep 30 2021US$14mUS$1m

US$2b

Jun 30 2021n/an/a

US$1b

Mar 31 2021n/an/a

US$1b

Dec 31 2020n/an/a

US$2b

Sep 30 2020US$12mUS$952k

US$245m

Jun 30 2020n/an/a

US$786m

Mar 31 2020n/an/a

US$923m

Dec 31 2019n/an/a

US$760m

Sep 30 2019US$6mUS$900k

US$1b

Jun 30 2019n/an/a

US$784m

Mar 31 2019n/an/a

US$926m

Dec 31 2018n/an/a

US$894m

Sep 30 2018US$6mUS$850k

US$159m

Jun 30 2018n/an/a

US$621m

Mar 31 2018n/an/a

-US$99m

Dec 31 2017n/an/a

US$294m

Sep 30 2017US$4mUS$761k

US$1b

Vergütung im Vergleich zum Markt: TomDie Gesamtvergütung ($USD17.31M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD13.51M).

Entschädigung vs. Einkommen: TomDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Tom Polen (50 yo)

7.1yrs

Amtszeit

US$17,309,938

Vergütung

Mr. Thomas E. Polen, Jr., also known as Tom, serves as Chief Executive Officer and Director at Becton, Dickinson and Company since January 28, 2020. Mr. Polen has been Director at Walgreens Boots Alliance,...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Thomas Polen
President7.1yrsUS$17.31m0.020%
$ 13.6m
Christopher DelOrefice
Executive VP & CFO2.7yrsUS$5.21m0.0014%
$ 945.3k
Shana Neal
Executive VP & Chief People Officer2.1yrsUS$5.89m0.0057%
$ 3.8m
David Hickey
Executive VP & President of Life Sciences Segment3.3yrsUS$3.35m0.0043%
$ 2.8m
Michael Garrison
Executive VP & President of Medical segment1.7yrsUS$3.65m0.0019%
$ 1.2m
Thomas Spoerel
Senior VP4.6yrskeine Daten0.00083%
$ 552.6k
Elizabeth McCombs
Executive VP & Chief Technology Officer3.1yrskeine Datenkeine Daten
Joseph Smith
Senior VP2.5yrskeine Datenkeine Daten
Denise Fleming
Executive VP of Technology & Global Services and Chief Information Officer2.3yrskeine Datenkeine Daten
Greg Rodetis
Head of Investor Relationsless than a yearkeine Datenkeine Daten
Michelle Quinn
Executive VP & General Counsel1.3yrskeine Daten0.0017%
$ 1.1m
Claudia Curtis
Senior VPno datakeine Datenkeine Daten

2.5yrs

Durchschnittliche Betriebszugehörigkeit

53yo

Durchschnittliches Alter

Erfahrenes Management: BDXDas Führungsteam des Unternehmens gilt als erfahren (2.4 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Thomas Polen
President4.3yrsUS$17.31m0.020%
$ 13.6m
Joseph Smith
Senior VP2.5yrskeine Datenkeine Daten
John DeFord
Co-Chair of Scientific Advisory Board3yrskeine Datenkeine Daten
Robert Eckert
Independent Director7.7yrsUS$362.77k0.0028%
$ 1.9m
Timothy Ring
Independent Director7.3yrsUS$332.78k0.020%
$ 13.6m
Jeffrey Henderson
Independent Director5.8yrsUS$357.78k0.0019%
$ 1.3m
Christopher Ian Jones
Independent Director13.8yrsUS$362.78k0.0074%
$ 4.9m
Bertram Scott
Lead Independent Director21.7yrsUS$372.78k0.012%
$ 8.1m
Catherine Burzik
Independent Director11.3yrsUS$357.78k0.0046%
$ 3.0m
William Brown
Independent Director2.3yrsUS$332.78k0.00087%
$ 579.2k
Claire Fraser-Liggett
Member of Scientific Advisory Board & Independent Director17.5yrsUS$340.15k0.0078%
$ 5.2m
Carrie Byington
Independent Director2.6yrsUS$337.78k0.00099%
$ 659.1k

6.5yrs

Durchschnittliche Betriebszugehörigkeit

61yo

Durchschnittliches Alter

Erfahrener Vorstand: BDXDie Vorstandsmitglieder gelten als erfahren (6.5 Jahre durchschnittliche Amtszeit).